{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:12:19Z","timestamp":1792001539007,"version":"4.4.0"},"reference-count":150,"publisher":"The Endocrine Society","issue":"2","license":[{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The significant and growing global prevalence of diabetes continues to challenge people with diabetes (PwD), healthcare providers, and payers. While maintaining near-normal glucose levels has been shown to prevent or delay the progression of the long-term complications of diabetes, a significant proportion of PwD are not attaining their glycemic goals. During the past 6 years, we have seen tremendous advances in automated insulin delivery (AID) technologies. Numerous randomized controlled trials and real-world studies have shown that the use of AID systems is safe and effective in helping PwD achieve their long-term glycemic goals while reducing hypoglycemia risk. Thus, AID systems have recently become an integral part of diabetes management. However, recommendations for using AID systems in clinical settings have been lacking. Such guided recommendations are critical for AID success and acceptance. All clinicians working with PwD need to become familiar with the available systems in order to eliminate disparities in diabetes quality of care. This report provides much-needed guidance for clinicians who are interested in utilizing AIDs and presents a comprehensive listing of the evidence payers should consider when determining eligibility criteria for AID insurance coverage.<\/jats:p>","DOI":"10.1210\/endrev\/bnac022","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T10:25:04Z","timestamp":1662459904000},"page":"254-280","source":"Crossref","is-referenced-by-count":417,"title":["Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice"],"prefix":"10.1210","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6616-5612","authenticated-orcid":false,"given":"Moshe","family":"Phillip","sequence":"first","affiliation":[{"name":"The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children\u2019s Medical Center of Israel , 49202 Petah Tikva , Israel"},{"name":"Sacker Faculty of Medicine, Tel-Aviv University , 39040 Tel-Aviv , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3571-4938","authenticated-orcid":false,"given":"Revital","family":"Nimri","sequence":"additional","affiliation":[{"name":"The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children\u2019s Medical Center of Israel , 49202 Petah Tikva , Israel"},{"name":"Sacker Faculty of Medicine, Tel-Aviv University , 39040 Tel-Aviv , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9050-5584","authenticated-orcid":false,"given":"Richard M","family":"Bergenstal","sequence":"additional","affiliation":[{"name":"International Diabetes Center, HealthPartners Institute , Minneapolis, MN 55416 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3888-3123","authenticated-orcid":false,"given":"Katharine","family":"Barnard-Kelly","sequence":"additional","affiliation":[{"name":"Southern Health NHS Foundation Trust , Southampton , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8424-3944","authenticated-orcid":false,"given":"Thomas","family":"Danne","sequence":"additional","affiliation":[{"name":"AUF DER BULT, Diabetes-Center for Children and Adolescents, Endocrinology and General Paediatrics , Hannover , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2901-461X","authenticated-orcid":false,"given":"Roman","family":"Hovorka","sequence":"additional","affiliation":[{"name":"Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge , Cambridge , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0495-3901","authenticated-orcid":false,"given":"Boris P","family":"Kovatchev","sequence":"additional","affiliation":[{"name":"Center for Diabetes Technology, School of Medicine, University of Virginia , Charlottesville, VA 22903 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7493-0989","authenticated-orcid":false,"given":"Laurel H","family":"Messer","sequence":"additional","affiliation":[{"name":"Barbara Davis Center for Diabetes, University of Colorado Denver\u2014Anschutz Medical Campus , Aurora, CO 80045 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6838-5355","authenticated-orcid":false,"given":"Christopher G","family":"Parkin","sequence":"additional","affiliation":[{"name":"CGParkin Communications, Inc. , Henderson, NV , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Ambler-Osborn","sequence":"additional","affiliation":[{"name":"Joslin Diabetes Center, Harvard Medical School , Boston, MA 02215 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2686-5531","authenticated-orcid":false,"given":"Stephanie A","family":"Amiel","sequence":"additional","affiliation":[{"name":"Department of Diabetes, King\u2019s College London , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1993-7672","authenticated-orcid":false,"given":"Lia","family":"Bally","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Bern University Hospital and University of Bern , Bern , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5194-8446","authenticated-orcid":false,"given":"Roy W","family":"Beck","sequence":"additional","affiliation":[{"name":"Jaeb Center for Health Research Foundation, Inc. , Tampa, FL 33647 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Biester","sequence":"additional","affiliation":[{"name":"AUF DER BULT, Diabetes-Center for Children and Adolescents, Endocrinology and General Paediatrics , Hannover , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8051-5562","authenticated-orcid":false,"given":"Torben","family":"Biester","sequence":"additional","affiliation":[{"name":"AUF DER BULT, Diabetes-Center for Children and Adolescents, Endocrinology and General Paediatrics , Hannover , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6714-4792","authenticated-orcid":false,"given":"Julia E","family":"Blanchette","sequence":"additional","affiliation":[{"name":"College of Nursing, University of Utah , Salt Lake City, UT 84112 , USA"},{"name":"Center for Diabetes and Obesity, University Hospitals Cleveland Medical Center , Cleveland, OH 44106 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Bosi","sequence":"additional","affiliation":[{"name":"Diabetes Research Institute, IRCCS San Raffaele Hospital and San Raffaele Vita Salute University , Milan , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3272-9544","authenticated-orcid":false,"given":"Charlotte K","family":"Boughton","sequence":"additional","affiliation":[{"name":"Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke\u2019s Hospital, University of Cambridge Metabolic Research Laboratories , Cambridge , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7645-2693","authenticated-orcid":false,"given":"Marc D","family":"Breton","sequence":"additional","affiliation":[{"name":"Center for Diabetes Technology, School of Medicine, University of Virginia , Charlottesville, VA 22903 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8658-6270","authenticated-orcid":false,"given":"Sue A","family":"Brown","sequence":"additional","affiliation":[{"name":"Center for Diabetes Technology, School of Medicine, University of Virginia , Charlottesville, VA 22903 , USA"},{"name":"Division of Endocrinology, University of Virginia , Charlottesville, VA 22903 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4581-4887","authenticated-orcid":false,"given":"Bruce A","family":"Buckingham","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Stanford University, School of Medicine , Stanford, CA 94304 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Cai","sequence":"additional","affiliation":[{"name":"The diaTribe Foundation\/Close Concerns , San Diego, CA 94117 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5738-2818","authenticated-orcid":false,"given":"Anders L","family":"Carlson","sequence":"additional","affiliation":[{"name":"International Diabetes Center, HealthPartners Institute , Minneapolis, MN 55416 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1179-5374","authenticated-orcid":false,"given":"Jessica R","family":"Castle","sequence":"additional","affiliation":[{"name":"Harold Schnitzer Diabetes Health Center, Oregon Health & Science University , Portland, OR 97239 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7635-4735","authenticated-orcid":false,"given":"Pratik","family":"Choudhary","sequence":"additional","affiliation":[{"name":"Diabetes Research Centre, University of Leicester , Leicester , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly L","family":"Close","sequence":"additional","affiliation":[{"name":"The diaTribe Foundation\/Close Concerns , San Diego, CA 94117 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0169-6682","authenticated-orcid":false,"given":"Claudio","family":"Cobelli","sequence":"additional","affiliation":[{"name":"Department of Woman and Child\u2019s Health, University of Padova , Padova , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy B","family":"Criego","sequence":"additional","affiliation":[{"name":"International Diabetes Center, HealthPartners Institute , Minneapolis, MN 55416 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4244-5473","authenticated-orcid":false,"given":"Elizabeth","family":"Davis","sequence":"additional","affiliation":[{"name":"Telethon Kids Institute, University of Western Australia, Perth Children\u2019s Hospital , Perth , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4310-6799","authenticated-orcid":false,"given":"Carine","family":"de Beaufort","sequence":"additional","affiliation":[{"name":"Diabetes & Endocrine Care Clinique P\u00e9diatrique DECCP\/Centre Hospitalier Luxembourg, and Faculty of Sciences, Technology and Medicine, University of Luxembourg, Esch sur Alzette, GD Luxembourg\/Department of Paediatrics, UZ-VUB , Brussels , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0454-6679","authenticated-orcid":false,"given":"Martin I","family":"de Bock","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University of Otago , Christchurch , New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0440-3339","authenticated-orcid":false,"given":"Daniel J","family":"DeSalvo","sequence":"additional","affiliation":[{"name":"Division of Pediatric Diabetes and Endocrinology, Baylor College of Medicine, Texas Children\u2019s Hospital , Houston, TX 77598 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9196-9906","authenticated-orcid":false,"given":"J Hans","family":"DeVries","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, University of Amsterdam, Internal Medicine , Amsterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9201-2145","authenticated-orcid":false,"given":"Klemen","family":"Dovc","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology, Diabetes and Metabolic Diseases, UMC - University Children\u2019s Hospital, Ljubljana, Slovenia, and Faculty of Medicine, University of Ljubljana , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Francis J","family":"Doyle","sequence":"additional","affiliation":[{"name":"Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University , Cambridge, MA 02138 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3263-1419","authenticated-orcid":false,"given":"Laya","family":"Ekhlaspour","sequence":"additional","affiliation":[{"name":"Lucile Packard Children\u2019s Hospital\u2014Pediatric Endocrinology, Stanford University School of Medicine , Palo Alto, CA 94304 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9612-6983","authenticated-orcid":false,"given":"Naama Fisch","family":"Shvalb","sequence":"additional","affiliation":[{"name":"The Jesse Z and Sara Lea Shafer Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children\u2019s Medical Center of Israel , 49202 Petah Tikva , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory P","family":"Forlenza","sequence":"additional","affiliation":[{"name":"Barbara Davis Center for Diabetes, University of Colorado Denver\u2014Anschutz Medical Campus , Aurora, CO 80045 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"Gallen","sequence":"additional","affiliation":[{"name":"Department of Diabetes, King\u2019s College London , London , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish K","family":"Garg","sequence":"additional","affiliation":[{"name":"Barbara Davis Center for Diabetes, University of Colorado Denver\u2014Anschutz Medical Campus , Aurora, CO 80045 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana C","family":"Gershenoff","sequence":"additional","affiliation":[{"name":"International Diabetes Center, HealthPartners Institute , Minneapolis, MN 55416 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3009-2626","authenticated-orcid":false,"given":"Linda A","family":"Gonder-Frederick","sequence":"additional","affiliation":[{"name":"Center for Diabetes Technology, School of Medicine, University of Virginia , Charlottesville, VA 22903 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Haidar","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, McGill University , Montreal , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Hartnell","sequence":"additional","affiliation":[{"name":"Wolfson Diabetes and Endocrine Clinic, Cambridge University Hospitals NHS Foundation Trust , Cambridge , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2493-1304","authenticated-orcid":false,"given":"Lutz","family":"Heinemann","sequence":"additional","affiliation":[{"name":"Science Consulting in Diabetes GmbH , Kaarst , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Heller","sequence":"additional","affiliation":[{"name":"Department of Oncology and Metabolism, University of Sheffield , Sheffield , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1675-8417","authenticated-orcid":false,"given":"Irl B","family":"Hirsch","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Washington Diabetes Institute, University of Washington , Seattle, WA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5730-7749","authenticated-orcid":false,"given":"Korey K","family":"Hood","sequence":"additional","affiliation":[{"name":"Stanford Diabetes Research Center, Stanford University School of Medicine , Stanford, CA 94305 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5743-9458","authenticated-orcid":false,"given":"Diana","family":"Isaacs","sequence":"additional","affiliation":[{"name":"Cleveland Clinic, Endocrinology and Metabolism Institute , Cleveland, OH 44106 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C","family":"Klonoff","sequence":"additional","affiliation":[{"name":"Diabetes Research Institute, Mills-Peninsula Medical Center , San Mateo, CA 94010 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Kordonouri","sequence":"additional","affiliation":[{"name":"AUF DER BULT, Diabetes-Center for Children and Adolescents, Endocrinology and General Paediatrics , Hannover , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Kowalski","sequence":"additional","affiliation":[{"name":"JDRF International , New York, NY 10281 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9675-3001","authenticated-orcid":false,"given":"Lori","family":"Laffel","sequence":"additional","affiliation":[{"name":"Joslin Diabetes Center, Harvard Medical School , Boston, MA 02215 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Lawton","sequence":"additional","affiliation":[{"name":"Usher Institute, University of Edinburgh , Edinburgh , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8055-944X","authenticated-orcid":false,"given":"Rayhan A","family":"Lal","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Stanford University School of Medicine , Stanford, CA 94305 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9602-1962","authenticated-orcid":false,"given":"Lalantha","family":"Leelarathna","sequence":"additional","affiliation":[{"name":"Manchester University Hospitals NHS Foundation Trust\/University of Manchester , Manchester , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4602-7909","authenticated-orcid":false,"given":"David M","family":"Maahs","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Pediatrics, Stanford University, School of Medicine , Stanford, CA 94304 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen R","family":"Murphy","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia , Norwich , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"N\u00f8rgaard","sequence":"additional","affiliation":[{"name":"Steno Diabetes Center Copenhagen and Department of Clinical Medicine, University of Copenhagen , Gentofte , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"O\u2019Neal","sequence":"additional","affiliation":[{"name":"Department of Medicine and Department of Endocrinology, St Vincent\u2019s Hospital Melbourne, University of Melbourne , Melbourne , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9640-3087","authenticated-orcid":false,"given":"Sean","family":"Oser","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, University of Colorado School of Medicine, Anschutz Medical Campus , Aurora, CO 80045 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0405-3420","authenticated-orcid":false,"given":"Tamara","family":"Oser","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, University of Colorado School of Medicine, Anschutz Medical Campus , Aurora, CO 80045 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3407-7263","authenticated-orcid":false,"given":"Eric","family":"Renard","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes, Nutrition, Montpellier University Hospital, and Institute of Functional Genomics, University of Montpellier, CNRS, INSERM , Montpellier , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6556-7559","authenticated-orcid":false,"given":"Michael C","family":"Riddell","sequence":"additional","affiliation":[{"name":"School of Kinesiology & Health Science, Muscle Health Research Centre, York University , Toronto , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5547-3564","authenticated-orcid":false,"given":"David","family":"Rodbard","sequence":"additional","affiliation":[{"name":"Biomedical Informatics Consultants LLC , Potomac, MD , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J","family":"Russell","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital and Harvard Medical School , Boston, MA , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1044-5762","authenticated-orcid":false,"given":"Desmond A","family":"Schatz","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, College of Medicine, Diabetes Institute, University of Florida , Gainesville, FL 02114 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3827-7107","authenticated-orcid":false,"given":"Viral N","family":"Shah","sequence":"additional","affiliation":[{"name":"Barbara Davis Center for Diabetes, University of Colorado Denver\u2014Anschutz Medical Campus , Aurora, CO 80045 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9301-3043","authenticated-orcid":false,"given":"Jennifer L","family":"Sherr","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Yale University School of Medicine, Pediatric Endocrinology , New Haven, CT 06511 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5561-2547","authenticated-orcid":false,"given":"Gregg D","family":"Simonson","sequence":"additional","affiliation":[{"name":"International Diabetes Center, HealthPartners Institute , Minneapolis, MN 55416 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4139-2122","authenticated-orcid":false,"given":"R Paul","family":"Wadwa","sequence":"additional","affiliation":[{"name":"Barbara Davis Center for Diabetes, University of Colorado Denver\u2014Anschutz Medical Campus , Aurora, CO 80045 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice","family":"Ward","sequence":"additional","affiliation":[{"name":"Institute of Metabolic Science, Cambridge University Hospitals NHS Foundation Trust , Cambridge , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7768-5189","authenticated-orcid":false,"given":"Stuart A","family":"Weinzimer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Yale University School of Medicine, Pediatric Endocrinology , New Haven, CT 06511 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8698-6207","authenticated-orcid":false,"given":"Emma G","family":"Wilmot","sequence":"additional","affiliation":[{"name":"Department of Diabetes & Endocrinology, University Hospitals of Derby and Burton NHS Trust , Derby , UK"},{"name":"Division of Medical Sciences and Graduate Entry Medicine, University of Nottingham , Nottingham, England , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0273-4732","authenticated-orcid":false,"given":"Tadej","family":"Battelino","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology, Diabetes and Metabolic Diseases, UMC - University Children\u2019s Hospital, Ljubljana, Slovenia, and Faculty of Medicine, University of Ljubljana , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"issue":"2","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/dia.2018.0384","article-title":"State of type 1 diabetes management and outcomes from the T1D Exchange in 2016\u20132018","volume":"21","author":"Foster","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"18","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1056\/NEJMoa1907863","article-title":"Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes","volume":"381","author":"Brown","year":"2019","journal-title":"N Engl J Med"},{"issue":"5","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1089\/dia.2020.0572","article-title":"Closed-loop insulin therapy improves glycemic control in adolescents and young adults: outcomes from the international diabetes closed-loop trial","volume":"23","author":"Isganaitis","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.2337\/dc20-1447","article-title":"Six months of hybrid closed-loop versus manual insulin delivery with fingerprick blood glucose monitoring in adults with type 1 diabetes: a randomized, controlled trial","volume":"43","author":"McAuley","year":"2020","journal-title":"Diabetes Care"},{"issue":"4","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2337\/dc20-2250","article-title":"Improved glycemic outcomes with Medtronic MiniMed advanced hybrid closed-loop delivery: results from a randomized crossover trial comparing automated insulin delivery with predictive low glucose suspend in people with type 1 diabetes","volume":"44","author":"Collyns","year":"2021","journal-title":"Diabetes Care"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(18)31947-0","article-title":"Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial","volume":"392","author":"Tauschmann","year":"2018","journal-title":"Lancet"},{"issue":"11","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1089\/dia.2020.0064","article-title":"Cost-effectiveness analysis of a hybrid closed-loop system versus multiple daily injections and capillary glucose testing for adults with type 1 diabetes","volume":"22","author":"Pease","year":"2020","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1089\/dia.2018.0328","article-title":"Cost-effectiveness analysis of the MiniMed 670G hybrid closed-loop system versus continuous subcutaneous insulin infusion for treatment of type 1 diabetes","volume":"21","author":"Jendle","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"Suppl 3","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"S447","DOI":"10.1016\/j.ijmedinf.2007.06.002","article-title":"HIS modelling and simulation based cost-benefit analysis of a telemedical system for closed-loop diabetes therapy","volume":"76","author":"Bott","year":"2007","journal-title":"Int J Med Inform"},{"issue":"4","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1007\/s12325-022-02058-9","article-title":"Cost-effectiveness of hybrid closed loop insulin pumps versus multiple daily injections plus intermittently scanned glucose monitoring in people with type 1 diabetes in The Netherlands","volume":"39","author":"Sern\u00e9","year":"2022","journal-title":"Adv Ther"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.2337\/diabetes.52.11.2790","article-title":"Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor","volume":"52","author":"Boyne","year":"2003","journal-title":"Diabetes"},{"issue":"3","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/dme.13525","article-title":"Optimal prandial timing of bolus insulin in diabetes management: a review","volume":"35","author":"Slattery","year":"2018","journal-title":"Diabet Med"},{"issue":"6","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.2337\/dc20-1086","article-title":"Performance of the insulin-only iLet bionic pancreas and the bihormonal iLet using dasiglucagon in adults with type 1 diabetes in a home-use setting","volume":"44","author":"Castellanos","year":"2021","journal-title":"Diabetes Care"},{"issue":"3","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2337\/dc19-1922","article-title":"A novel dual-hormone insulin-and-pramlintide artificial pancreas for type 1 diabetes: a randomized controlled crossover trial","volume":"43","author":"Haidar","year":"2020","journal-title":"Diabetes Care"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3390\/a2010518","article-title":"A review of closed-loop algorithms for glycemic control in the treatment of type 1 diabetes","volume":"2","author":"Youssef J","year":"2009","journal-title":"Algorithms"},{"issue":"5","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1089\/dia.2017.0424","article-title":"Fully closed-loop multiple model probabilistic predictive controller artificial pancreas performance in adolescents and adults in a supervised hotel setting","volume":"20","author":"Forlenza","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1001\/jama.2016.11708","article-title":"Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes","volume":"316","author":"Bergenstal","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/dia.2018.0264","article-title":"Safety evaluation of the MiniMed 670g system in children 7-13 years of age with type 1 diabetes","volume":"21","author":"Forlenza","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.2337\/dc20-0124","article-title":"Glycemic outcomes of use of CLC versus PLGS in type 1 diabetes: a randomized controlled trial","volume":"43","author":"Brown","year":"2020","journal-title":"Diabetes Care"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJMoa2004736","article-title":"A randomized trial of closed-loop control in children with type 1 diabetes","volume":"383","author":"Breton","year":"2020","journal-title":"N Engl J Med"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.2337\/dc21-0172","article-title":"Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes","volume":"44","author":"Brown","year":"2021","journal-title":"Diabetes Care"},{"issue":"3","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1089\/dia.2021.0319","article-title":"Safety and glycemic outcomes during the MiniMed\u2122 Advanced Hybrid Closed-Loop system pivotal trial in adolescents and adults with type 1 diabetes","volume":"24","author":"Carlson","year":"2022","journal-title":"Diabetes Technol Ther"},{"issue":"10270","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0140-6736(20)32514-9","article-title":"A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial","volume":"397","author":"Bergenstal","year":"2021","journal-title":"Lancet"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/S2589-7500(19)30003-2","article-title":"Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial","volume":"1","author":"Benhamou","year":"2019","journal-title":"Lancet Digital Health"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1016\/S2589-7500(21)00271-5","article-title":"Hybrid closed-loop insulin delivery versus sensor-augmented pump therapy in children aged 6-12 years: a randomised, controlled, cross-over, non-inferiority trial","volume":"4","author":"Kariyawasam","year":"2022","journal-title":"Lancet Digit Health"},{"issue":"3","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2337\/dc20-2106","article-title":"Fully closed loop glucose control with a bihormonal artificial pancreas in adults with type 1 diabetes: an outpatient, randomized, crossover trial","volume":"44","author":"Blauw","year":"2021","journal-title":"Diabetes Care"},{"issue":"5","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/dia.2020.0535","article-title":"A real-world prospective study of the safety and effectiveness of the loop open source automated insulin delivery system","volume":"23","author":"Lum","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"2023030413294574500_","author":"Ware"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1016\/S2666-7568(22)00005-8","article-title":"Hybrid closed-loop glucose control with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover study","author":"Boughton","year":"2022","journal-title":"Lancet Healthy Longevity"},{"issue":"3","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/dia.2016.0421","article-title":"Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes","volume":"19","author":"Garg","year":"2017","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/pedi.13312","article-title":"Glycemic outcomes of children 2-6 years of age with type 1 diabetes during the pediatric MiniMed\u2122 670G system trial","volume":"23","author":"Forlenza","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","article-title":"Safety and glycemic outcomes with a tubeless automated insulin delivery system in very young children with type 1 diabetes: a single-arm multicenter clinical trial","author":"Sherr","DOI":"10.2337\/dc21-2359"},{"issue":"7","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/dia.2020.0646","article-title":"Predictors of time-in-range (70-180 mg\/dL) achieved using a closed-loop control system","volume":"23","author":"Schoelwer","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1089\/dia.2021.0524","article-title":"Glycemic outcomes in baseline hemoglobin A1C subgroups in the international diabetes closed-loop trial","volume":"24","author":"Ekhlaspour","year":"2022","journal-title":"Diabetes Technol Ther"},{"issue":"9","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/dia.2021.0097","article-title":"One year real-world use of the control-IQ advanced hybrid closed-loop technology","volume":"23","author":"Breton","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":". The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin-dependent diabetes mellitus","volume":"329","author":"Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Engl J Med"},{"issue":"10","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1089\/dia.2018.0202","article-title":"Retrospective analysis of 3-month real-world glucose data after the MiniMed 670G system commercial launch","volume":"20","author":"Stone","year":"2018","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/dom.13933","article-title":"Long-term real-life glycaemic outcomes with a hybrid closed-loop system compared with sensor-augmented pump therapy in patients with type 1 diabetes","volume":"22","author":"Akturk","year":"2020","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/dia.2021.0037","article-title":"Rapid improvement in time in range after the implementation of an advanced hybrid closed-loop system in adolescents and adults with type 1 diabetes","volume":"23","author":"Beato-V\u00edbora","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/dia.2021.0203","article-title":"Real-world performance of the MiniMed 780G system: first Report of outcomes from 4120 Users","volume":"24","author":"Da Silva","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1089\/dia.2021.0165","article-title":"Real-world use of a new hybrid closed loop improves glycemic control in youth with type 1 diabetes","volume":"23","author":"Messer","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"2023030413294574500_","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14815","article-title":"Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parents.","author":"Hood","year":"2022","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1089\/dia.2020.0057","article-title":"Impact of the hybrid closed-loop system on sleep and quality of life in youth with type 1 diabetes and their parents","volume":"22","author":"Cobry","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1001\/jamapediatrics.2021.3965","article-title":"Effect of a hybrid closed-loop system on glycemic and psychosocial outcomes in children and adolescents with type 1 diabetes: a randomized clinical trial","volume":"175","author":"Abraham","year":"2021","journal-title":"JAMA Pediatr"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/pedi.12971","article-title":"Real world hybrid closed-loop discontinuation: predictors and perceptions of youth discontinuing the 670G system in the first 6 months","volume":"21","author":"Messer","year":"2020","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/pedi.12962","article-title":"Six months of hybrid closed loop in the real-world: an evaluation of children and young adults using the 670G system","volume":"21","author":"Berget","year":"2020","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"95","DOI":"10.7326\/M16-2596","article-title":"Racial differences in the relationship of glucose concentrations and hemoglobin A1c levels","volume":"167","author":"Bergenstal","year":"2017","journal-title":"Ann Intern Med"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"590308","DOI":"10.1155\/2015\/590308","article-title":"Reduced worries of hypoglycaemia, high satisfaction, and increased perceived ease of use after experiencing four nights of MD-logic artificial pancreas at home (DREAM4)","volume":"2015","author":"Ziegler","year":"2015","journal-title":"J Diabetes Res"},{"issue":"6","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/dia.2020.0532","article-title":"Health-related quality of life and treatment satisfaction in parents and children with type 1 diabetes using closed-loop control","volume":"23","author":"Cobry","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/pedi.13164","article-title":"Sleep and diabetes-specific psycho-behavioral outcomes of a new automated insulin delivery system in young children with type 1 diabetes and their parents","volume":"22","author":"Bisio","year":"2021","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00592-021-01789-5","article-title":"Improved technology satisfaction and sleep quality with Medtronic MiniMed Advanced Hybrid Closed-Loop delivery compared to predictive low glucose suspend in people with type 1 diabetes in a randomized crossover trial","volume":"59","author":"Wheeler","year":"2021","journal-title":"Acta Diabetol"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1089\/dia.2021.0089","article-title":"Patient-reported outcomes in a randomized trial of closed-loop control: the pivotal international diabetes closed-loop trial","volume":"23","author":"Kudva","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.2337\/dc21-1778","article-title":"Improvements in parental sleep, fear of hypoglycemia, and diabetes distress with use of an advanced hybrid closed loop system","volume":"45","author":"Cobry","year":"2022","journal-title":"Diabetes Care"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1177\/1932296817702656","article-title":"Closing the loop in adults, children and adolescents with sub-ptimally controlled type 1 diabetes under free living conditions: a psychosocial substudy","volume":"11","author":"Barnard","year":"2017","journal-title":"J Diabetes Sci Technol"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"594","DOI":"10.2337\/dc18-1881","article-title":"Home use of day-and-night hybrid closed-loop insulin delivery in very young children: a multicenter, 3-week, randomized trial","volume":"42","author":"Tauschmann","year":"2019","journal-title":"Diabetes Care"},{"issue":"5","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1089\/dia.2020.0507","article-title":"Safety and performance of the Tandem t:slim X2 with control-IQ automated insulin delivery system in toddlers and preschoolers","volume":"23","author":"Ekhlaspour","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1089\/dia.2019.0123","article-title":"Efficacy and safety of real-life usage of MiniMed 670G automode in children with type 1 diabetes less than 7 years old","volume":"21","author":"Salehi","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1602494","article-title":"Closed-loop insulin delivery during pregnancy in women with type 1 diabetes","volume":"375","author":"Stewart","year":"2016","journal-title":"N Engl J Med"},{"issue":"7","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.2337\/dc17-2534","article-title":"Day-and-night closed-loop insulin delivery in a broad population of pregnant women with type 1 diabetes: a randomized controlled crossover trial","volume":"41","author":"Stewart","year":"2018","journal-title":"Diabetes Care"},{"issue":"5","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2337\/dc13-1030","article-title":"Feasibility of closed-loop insulin delivery in type 2 diabetes: a randomized controlled study","volume":"37","author":"Kumareswaran","year":"2014","journal-title":"Diabetes Care"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2213-8587(16)30280-7","article-title":"Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial","volume":"5","author":"Thabit","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.2337\/dc20-3063","article-title":"Inequity in racial-ethnic representation in randomized controlled trials of diabetes technologies in type 1 diabetes: critical need for new standards","volume":"44","author":"Akturk","year":"2021","journal-title":"Diabetes Care"},{"issue":"2","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/17425247.2020.1713747","article-title":"Closed-loop insulin delivery systems in children and adolescents with type 1 diabetes","volume":"17","author":"Dovc","year":"2020","journal-title":"Expert Opin Drug Deliv"},{"issue":"3","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1089\/dia.2019.0286","article-title":"Safety and performance of the Omnipod hybrid closed-loop system in adults, adolescents, and children with type 1 diabetes over 5 days under free-living conditions","volume":"22","author":"Sherr","year":"2020","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.2337\/dc19-0855","article-title":"One year clinical experience of the first commercial hybrid closed-loop system","volume":"42","author":"Lal","year":"2019","journal-title":"Diabetes Care"},{"issue":"7","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"e14087","DOI":"10.2196\/14087","article-title":"Real-world use of Do-It-Yourself artificial pancreas systems in children and adolescents with type 1 diabetes: online survey and analysis of self-reported clinical outcomes","volume":"7","author":"Braune","year":"2019","journal-title":"JMIR Mhealth Uhealth"},{"issue":"6","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/pedi.13235","article-title":"First year on commercial hydrid closed-loop system - experience on 111 children and adolescents with type 1 diabetes","volume":"22","author":"Varimo","year":"2021","journal-title":"Pediatr Diabetes"},{"issue":"9","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1111\/dom.14441","article-title":"Real world performance of hybrid closed loop in youth, young adults, adults and older adults with type 1 diabetes: identifying a clinical target for hybrid closed loop use","volume":"23","author":"Berget","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2337\/dc21-1667","article-title":"Closed-loop insulin delivery versus sensor-augmented pump therapy in older adults with type 1 diabetes (ORACL): a randomized, crossover trial","volume":"45","author":"McAuley","year":"2022","journal-title":"Diabetes Care"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"679484","DOI":"10.3389\/fped.2021.679484","article-title":"Benefits and challenges of current closed-loop technologies in children and young people with type 1 diabetes","volume":"9","author":"Fuchs","year":"2021","journal-title":"Front Pediatr"},{"issue":"2","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"e042790","DOI":"10.1136\/bmjopen-2020-042790","article-title":"Assessing the efficacy, safety and utility of closed-loop insulin delivery compared with sensor-augmented pump therapy in very young children with type 1 diabetes (KidsAP02 study): an open-label, multicentre, multinational, randomised cross-over study protocol","volume":"11","author":"Fuchs","year":"2021","journal-title":"BMJ Open"},{"issue":"4","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/pedi.13190","article-title":"Pre-school and school-aged children benefit from the switch from a sensor-augmented pump to an AndroidAPS hybrid closed loop: a retrospective analysis","volume":"22","author":"Petruzelkova","year":"2021","journal-title":"Pediatr Diabetes"},{"issue":"7","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.2337\/dc18-2625","article-title":"Young children have higher variability of insulin requirements: observations during hybrid closed-loop insulin delivery","volume":"42","author":"Dovc","year":"2019","journal-title":"Diabetes Care"},{"issue":"6","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1089\/dia.2019.0018","article-title":"Hybrid closed-loop control is safe and effective for people with type 1 diabetes who are at moderate to high risk for hypoglycemia","volume":"21","author":"Anderson","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1089\/dia.2017.0353","article-title":"Overnight glucose control with dual- and single-hormone artificial pancreas in type 1 diabetes with hypoglycemia unawareness: a randomized controlled trial","volume":"20","author":"Abitbol","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"6611064","DOI":"10.1155\/2021\/6611064","article-title":"Characterizing glycemic control and sleep in adults with long-standing type 1 diabetes and hypoglycemia unawareness initiating hybrid closed loop insulin delivery","volume":"2021","author":"Malone","year":"2021","journal-title":"J Diabetes Res"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1089\/dia.2020.0593","article-title":"Impact of hybrid closed loop therapy on hypoglycemia awareness in individuals with type 1 diabetes and impaired hypoglycemia awareness","volume":"23","author":"Burckhardt","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"e3248","DOI":"10.1002\/dmrr.3248","article-title":"Case series of a hybrid closed-loop system used in pregnancies in clinical practice","volume":"36","author":"Polsky","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"issue":"6","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1177\/1932296818800065","article-title":"Women\u2019s experiences of day-and-night closed-loop insulin delivery during type 1 diabetes pregnancy","volume":"12","author":"Farrington","year":"2018","journal-title":"J Diabetes Sci Technol"},{"issue":"10","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/dme.13406","article-title":"Experiences of closed-loop insulin delivery among pregnant women with Type 1 diabetes","volume":"34","author":"Farrington","year":"2017","journal-title":"Diabet Med"},{"issue":"7","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/dia.2018.0060","article-title":"Adaptability of closed loop during labor, delivery, and postpartum: a secondary analysis of data from two randomized crossover trials in type 1 diabetes pregnancy","volume":"20","author":"Stewart","year":"2018","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.kint.2019.03.006","article-title":"Fully closed-loop insulin delivery improves glucose control of inpatients with type 2 diabetes receiving hemodialysis","volume":"96","author":"Bally","year":"2019","journal-title":"Kidney Int"},{"issue":"12","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1089\/dia.2019.0254","article-title":"Efficacy of hybrid closed-loop system in adults with type 1 diabetes and gastroparesis","volume":"21","author":"Kaur","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/s41591-021-01453-z","article-title":"Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial","volume":"27","author":"Boughton","year":"2021","journal-title":"Nat Med"},{"issue":"1","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jcf.2019.08.002","article-title":"Automated glycemic control with the bionic pancreas in cystic fibrosis-related diabetes: A pilot study","volume":"19","author":"Sherwood","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"6","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1089\/dia.2021.0354","article-title":"The effect of Control IQ\u2122 hybrid closed loop technology on glycemic control in adolescents and adults with cystic fibrosis related diabetes","volume":"24","author":"Scully","year":"2022","journal-title":"Diabetes Technol Ther"},{"issue":"Suppl 1","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.2337\/dc21-S016","article-title":"ADA evidence-grading system for \u201cStandards of Medical Care in Diabetes\u201d","volume":"44","author":"American Diabetes Association","year":"2021","journal-title":"Diabetes Care"},{"issue":"2","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1016\/S2589-7500(19)30218-3","article-title":"Evening and overnight closed-loop control versus 24\/7 continuous closed-loop control for type 1 diabetes: a randomised crossover trial","volume":"2","author":"Kovatchev","year":"2020","journal-title":"Lancet Digit Health"},{"key":"2023030413294574500_","author":"Carlson"},{"issue":"22","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa1509351","article-title":"Home use of an artificial beta cell in type 1 diabetes","volume":"373","author":"Thabit","year":"2015","journal-title":"N Engl J Med"},{"issue":"3","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/1932296820986879","article-title":"The impact of a recently approved automated insulin delivery system on glycemic, sleep, and psychosocial outcomes in older adults with type 1 diabetes: a pilot study","volume":"16","author":"Bisio","year":"2022","journal-title":"J Diabetes Sci Technol"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1056\/NEJMoa1805233","article-title":"Closed-loop insulin delivery for glycemic control in noncritical care","volume":"379","author":"Bally","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1089\/dia.2018.0257","article-title":"Glycemic outcomes with early initiation of continuous glucose monitoring system in recently diagnosed patients with type 1 diabetes","volume":"21","author":"Mulinacci","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2352-4642(20)30339-4","article-title":"Early versus delayed insulin pump therapy in children with newly diagnosed type 1 diabetes: results from the multicentre, prospective diabetes follow-up DPV registry","volume":"5","author":"Kamrath","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2337\/dc21-2004","article-title":"Continuous glucose monitoring initiation within first year of type 1 diabetes diagnosis is associated with improved glycemic outcomes: 7-year follow-up study","volume":"45","author":"Champakanath","year":"2022","journal-title":"Diabetes Care"},{"issue":"9","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1056\/NEJM198903023200902","article-title":"A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus","volume":"320","author":"Shah","year":"1989","journal-title":"N Engl J Med"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.2337\/dc13-1074","article-title":"Effectiveness of early intensive therapy on \u03b2-cell preservation in type 1 diabetes","volume":"36","author":"Buckingham","year":"2013","journal-title":"Diabetes Care"},{"key":"2023030413294574500_","author":"University of Cambridge"},{"key":"2023030413294574500_","author":"Jaeb Center for Health Research. Hybrid Closed Loop"},{"issue":"7","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/dia.2019.0026","article-title":"Early initiation of diabetes devices relates to improved glycemic control in children with recent-onset type 1 diabetes mellitus","volume":"21","author":"Patton","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1089\/dia.2019.0466","article-title":"What training, support, and resourcing do health professionals need to support people using a closed-loop system? A qualitative interview study with health professionals involved in the closed loop from onset in type 1 diabetes (CLOuD) trial","volume":"22","author":"Kimbell","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1089\/dia.2018.0116","article-title":"Why expectations will determine the future of artificial pancreas","volume":"20","author":"Messer","year":"2018","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1177\/1932296820955168","article-title":"Training and support for hybrid closed-loop therapy","volume":"16","author":"Boughton","year":"2022","journal-title":"J Diabetes Sci Technol"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1177\/1932296816663962","article-title":"Early detection of infusion set failure during insulin pump therapy in type 1 diabetes","volume":"10","author":"Cescon","year":"2016","journal-title":"J Diabetes Sci Technol"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1111\/dme.14116","article-title":"The importance of prandial insulin bolus timing with hybrid closed-loop systems","volume":"36","author":"Boughton","year":"2019","journal-title":"Diabet Med"},{"issue":"6","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/dia.2020.0602","article-title":"A virtual training program for the Tandem t:slim X2 insulin pump: implementation and outcomes","volume":"23","author":"Pinsker","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1089\/dia.2020.0234","article-title":"The effectiveness of virtual training on the MiniMed\u2122 670G system in people with type 1 diabetes during the COVID-19 pandemic","volume":"23","author":"Vigersky","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.dsx.2020.12.041","article-title":"Virtual training on the hybrid close loop system in people with type 1 diabetes (T1D) during the COVID-19 pandemic","volume":"15","author":"G\u00f3mez","year":"2021","journal-title":"Diabetes Metab Syndr"},{"issue":"6","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1177\/1932296820950753","article-title":"Successful initiation of hybrid closed-Loop system using virtual pump training program in a teenager with type 1 diabetes previously treated with multiple daily injections","volume":"15","author":"Petrovski","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/1932296819835183","article-title":"A clinical training program for hybrid closed loop therapy in a pediatric diabetes clinic","volume":"14","author":"Berget","year":"2020","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/pedi.13183","article-title":"Initiating hybrid closed loop: a program evaluation of an educator-led control-IQ follow-up at a large pediatric clinic","volume":"22","author":"Messer","year":"2021","journal-title":"Pediatr Diabetes"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"108169","DOI":"10.1016\/j.diabres.2020.108169","article-title":"Enhancing resources for healthcare professionals caring for people on intensive insulin therapy: summary from a national workshop","volume":"164","author":"Levine","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1089\/dia.2019.0105","article-title":"A clinical guide to advanced diabetes devices and closed-loop systems using the CARES paradigm","volume":"21","author":"Messer","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/1932296819851790","article-title":"A review of continuous glucose monitoring data interpretation in the age of automated insulin delivery","volume":"13","author":"Ekhlaspour","year":"2019","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2337\/dc17-1682","article-title":"Optimizing hybrid closed-loop therapy in adolescents and emerging adults using the MiniMed 670G system","volume":"41","author":"Messer","year":"2018","journal-title":"Diabetes Care"},{"issue":"4","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/dia.2020.0472","article-title":"Clinical management and pump parameter adjustment of the control-IQ closed-loop control system: results from a 6-month multicenter randomized clinical trial","volume":"23","author":"O\u2019Malley","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.2337\/dc20-1560","article-title":"Lower daily carbohydrate intake is associated with improved glycemic control in adults with type 1 diabetes using a hybrid closed-loop system","volume":"43","author":"Lehmann","year":"2020","journal-title":"Diabetes Care"},{"issue":"12","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2337\/dc17-1600","article-title":"International consensus on use of continuous glucose monitoring","volume":"40","author":"Danne","year":"2017","journal-title":"Diabetes Care"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.2337\/dci21-0043","article-title":"The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"44","author":"Holt","year":"2021","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.2337\/dc22-S006","article-title":"6. Glycemic targets: standards of medical care in diabetes\u20142022","volume":"45","author":"American Diabetes Association","year":"2022","journal-title":"Diabetes Care"},{"issue":"5","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/dia.2020.0622","article-title":"Standardized hybrid closed-loop system reporting","volume":"23","author":"Shah","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1177\/1932296816640289","article-title":"Psychosocial impact of the bionic pancreas during summer camp","volume":"10","author":"Weissberg-Benchell","year":"2016","journal-title":"J Diabetes Sci Technol"},{"issue":"12","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1089\/dia.2017.0174","article-title":"Impact of an automated bihormonal delivery system on psychosocial outcomes in adults with type 1 diabetes","volume":"19","author":"Weissberg-Benchell","year":"2017","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/dia.2018.0306","article-title":"Participants\u2019 experiences of, and views about, daytime use of a day-and-night hybrid closed-loop system in real life settings: longitudinal qualitative study","volume":"21","author":"Lawton","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1177\/1932296816635199","article-title":"Is psychological stress a factor for incorporation into future closed-loop systems?","volume":"10","author":"Gonder-Frederick","year":"2016","journal-title":"J Diabetes Sci Technol"},{"issue":"2","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2337\/cd19-0046","article-title":"Diabetes technologies: we are all in this together","volume":"38","author":"Oser","year":"2020","journal-title":"Clinical Diabetes"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s13300-020-00791-4","article-title":"Social inequalities and diabetes: a commentary","volume":"11","author":"Barnard-Kelly","year":"2020","journal-title":"Diabetes Ther"},{"key":"2023030413294574500_","author":"U.S. Food and Drug Administration"},{"issue":"15","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJMe2114651","article-title":"Striving for diversity in research studies","volume":"385","author":"Rubin","year":"2021","journal-title":"N Engl J Med"},{"issue":"7","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/jama.2021.13304","article-title":"Updated guidance on the reporting of race and ethnicity in medical and science journals","volume":"326","author":"Flanagin","year":"2021","journal-title":"JAMA"},{"issue":"6","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/dia.2021.0496","article-title":"Solutions to address inequity in diabetes technology use in type 1 diabetes: results from multidisciplinary stakeholder co-creation workshops","volume":"24","author":"Agarwal","year":"2022","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"e2960","DOI":"10.1210\/clinem\/dgaa236","article-title":"Racial-ethnic inequity in young adults with type 1 diabetes","volume":"105","author":"Agarwal","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2337\/dc20-0257","article-title":"A decade of disparities in diabetes technology use and HbA1c in pediatric type 1 diabetes: a transatlantic comparison","volume":"44","author":"Addala","year":"2021","journal-title":"Diabetes Care"},{"key":"2023030413294574500_","author":"U.S. Food & Drug Administration"},{"issue":"2","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"448","DOI":"10.2337\/dc20-1017","article-title":"Pharmacokinetics and pharmacodynamics of three different formulations of insulin aspart: a randomized, double-blind, crossover study in men with type 1 diabetes","volume":"44","author":"Svehlikova","year":"2021","journal-title":"Diabetes Care"},{"issue":"1","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2337\/dc19-0895","article-title":"Faster compared with standard insulin aspart during day-and-night fully closed-loop insulin therapy in type 1 diabetes: a double-blind randomized crossover trial","volume":"43","author":"Dovc","year":"2020","journal-title":"Diabetes Care"},{"issue":"6","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/dom.14355","article-title":"Hybrid closed-loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: a double-blind, multicentre, multinational, randomized, crossover study","volume":"23","author":"Boughton","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1111\/dom.12999","article-title":"Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control-based fully-automated artificial pancreas in patients with type 1 diabetes: a pilot study","volume":"19","author":"Dassau","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"2023030413294574500_","doi-asserted-by":"publisher","first-page":"19322968221076559","DOI":"10.1177\/19322968221076559","article-title":"Intraperitoneal insulin delivery: evidence of a physiological route for artificial pancreas from compartmental modeling","author":"Presti J","year":"2022","journal-title":"J Diabetes Sci Technol"},{"issue":"9","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.2337\/dc20-0091","article-title":"Effect of Afrezza on glucose dynamics during HCL treatment","volume":"43","author":"Galderisi","year":"2020","journal-title":"Diabetes Care"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2337\/dc16-0089","article-title":"Mitigating meal-related glycemic excursions in an insulin-sparing manner during closed-loop insulin delivery: the beneficial effects of adjunctive pramlintide and liraglutide","volume":"39","author":"Sherr","year":"2016","journal-title":"Diabetes Care"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/dom.14258","article-title":"Add-on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: the DAPADream study","volume":"23","author":"Biester","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/dom.14335","article-title":"Reducing the need for carbohydrate counting in type 1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: a randomized, controlled, non-inferiority, crossover pilot trial","volume":"23","author":"Haidar","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/pedi.13252","article-title":"Youth and parent preferences for an ideal AP system: it is all about reducing burden","volume":"22","author":"Commissariat","year":"2021","journal-title":"Pediatr Diabetes"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/0954411917702931","article-title":"In silico assessment of biomedical products: the conundrum of rare but not so rare events in two case studies","volume":"231","author":"Viceconti","year":"2017","journal-title":"Proc Inst Mech Eng H"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/dia.2016.0463","article-title":"Individually adaptive artificial pancreas in subjects with type 1 diabetes: a one-month proof-of-concept trial in free-living conditions","volume":"19","author":"Messori","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/btm2.10119","article-title":"Multivariate learning framework for long-term adaptation in the artificial pancreas","volume":"4","author":"Shi","year":"2018","journal-title":"Bioeng Transl Med"},{"issue":"1","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2337\/dci20-0048","article-title":"Racial and socioeconomic disparities in pediatric type 1 diabetes: time for a paradigm shift in approach","volume":"44","author":"Lipman","year":"2021","journal-title":"Diabetes Care"},{"issue":"7","key":"2023030413294574500_","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.2337\/dc20-2753","article-title":"Barriers to technology use and endocrinology care for underserved communities with type 1 diabetes","volume":"44","author":"Walker","year":"2021","journal-title":"Diabetes Care"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/edrv\/advance-article-pdf\/doi\/10.1210\/endrev\/bnac022\/46564127\/bnac022.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/edrv\/article-pdf\/44\/2\/254\/49423317\/bnac022.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/edrv\/article-pdf\/44\/2\/254\/49423317\/bnac022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T11:53:32Z","timestamp":1700999612000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/44\/2\/254\/6692818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":150,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,9,6]]},"published-print":{"date-parts":[[2023,3,4]]}},"URL":"https:\/\/doi.org\/10.1210\/endrev\/bnac022","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,4,1]]},"published":{"date-parts":[[2022,9,6]]}}}